$TXG

$72.96 +$1.41 (1.97%) Close

$TXG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 130.0M shares outstanding

Who owns TXG?

By type of holder

Institutions 98.7% Insiders 0.0% Everyone else 1.3%

Concentration Top 10 holders own 55.4%

FMR LLC 13.6% · ARK Investment Management LLC 7.7%

Institutional ownership

98.7%

+2.4 pts vs last qtr

Institutional holders

390

+60 vs last qtr

Net shares bought

+3.1M

by institutions in Q2 2026

New / sold out

99 / 39

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Price T Rowe Associates Inc /MD/ +4.4M
Citadel Advisors LLC +2.0M

Biggest sellers in Q2 2026

Millennium Management LLC −2.0M
ARK Investment Management LLC −1.7M

Who is planning to sell?

Notices of proposed sale, last 12 months

$16M

24 notices from 8 people

Shares covered

379.0K

0.29% of the company

Arranged in advance

53%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Serge Saxonov Director, ceo 10b5-1 $4.08M
Adam Taich Officer 10b5-1 $3M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2019–FY2025

+219.1%

+21.34% a year

Each share's claim on the business

−68.7%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $712M

over 7 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years69% 3–5 years8% 1–3 years8% Under 1 year15%

Quarterly turnover

14.3%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting TXG on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
F FMR LLC	17.6M	13.56%	−111.7K (−0.6%)	≤2021	0.0%
Shares held by quarter Peak holding17.7M (Q1'26) Change over 8 quarters+4.3M Share of the company13.560% FMR LLC's full portfolio →
AI ARK Investment Management LLC	10.0M	7.70%	−1.7M (−14.6%)	≤2021	2.5%
Shares held by quarter Peak holding13.9M (Q2'25) Change over 8 quarters−747.3K Share of the company7.700% ARK Investment Management LLC's full portfolio →

FMR LLC

17.6M

% of company

13.56%

Change vs last qtr

−111.7K (−0.6%)

Held since

≤2021

ARK Investment Management LLC

10.0M

% of company

7.70%

Change vs last qtr

−1.7M (−14.6%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding 10x Genomics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting TXG on Form N-PORT; together they hold 44.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
AI ARK Innovation ETF ARK ETF Trust	$184M	3.9M	2.99%	3.30%	July 31, 2026
AG ARK Genomic Revolution ETF ARK ETF Trust	$146M	3.1M	2.38%	9.39%	July 31, 2026

ARK Innovation ETF

ARK ETF Trust

Position value

$184M

% of company

2.99%

% of the fund

3.30%

As of

July 31, 2026

ARK Genomic Revolution ETF

ARK ETF Trust

Position value

$146M

% of company

2.38%

% of the fund

9.39%

As of

July 31, 2026

23 more funds behind a free account

See every fund holding 10x Genomics, Inc. and how much of the fund the position is.

Comments